Systems Biological Analysis of Epidermal Growth Factor Receptor Internalization Dynamics for Altered Receptor Levels*
暂无分享,去创建一个
Roland Eils | Hannah Schmidt-Glenewinkel | R. Eils | N. Brady | Nathan R Brady | Eileen Reinz | E. Reinz | Hannah Schmidt-Glenewinkel | Eileen Reinz
[1] D. Lauffenburger,et al. Computational modeling of the EGF-receptor system: a paradigm for systems biology. , 2003, Trends in cell biology.
[2] Toshio Yanagida,et al. Single-molecule imaging of EGFR signalling on the surface of living cells , 2000, Nature Cell Biology.
[3] Y. Yarden,et al. Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases , 2001, FEBS letters.
[4] L. Pelkmans,et al. Not just a sink: endosomes in control of signal transduction. , 2004, Current opinion in cell biology.
[5] P. Tan,et al. Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors , 2009, Breast Cancer Research and Treatment.
[6] Beverly Packard,et al. DPSS yellow‐green 561‐nm lasers for improved fluorochrome detection by flow cytometry , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[7] B. Kholodenko,et al. Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades , 2004, The Journal of cell biology.
[8] Y. Yarden,et al. p38 MAP kinase mediates stress‐induced internalization of EGFR: implications for cancer chemotherapy , 2006, The EMBO journal.
[9] J. Welsh,et al. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. , 1990, Science.
[10] H. Wiley,et al. Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. , 1990, The Journal of biological chemistry.
[11] I. Dikic,et al. Cbl–CIN85–endophilin complex mediates ligand-induced downregulation of EGF receptors , 2002, Nature.
[12] G. Carpenter,et al. All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired (*) , 1996, The Journal of Biological Chemistry.
[13] Y. Teramura,et al. Single‐molecule analysis of epidermal growth factor binding on the surface of living cells , 2006, EMBO Journal.
[14] Lucas Pelkmans,et al. Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae , 2005, Nature.
[15] Sandra L. Schmid,et al. Regulated portals of entry into the cell , 2003, Nature.
[16] T. Fleming,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.
[17] J. Post,et al. Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction , 2004, Nature Biotechnology.
[18] H. Wiley,et al. The endocytotic rate constant. A cellular parameter for quantitating receptor-mediated endocytosis. , 1982, The Journal of biological chemistry.
[19] E. Gilles,et al. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.
[20] Y. Yarden,et al. ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. , 1996, The EMBO journal.
[21] Bianca Habermann,et al. APPL Proteins Link Rab5 to Nuclear Signal Transduction via an Endosomal Compartment , 2004, Cell.
[22] P. Transidico,et al. Clathrin-independent endocytosis of ubiquitinated cargos. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] M. McNiven,et al. A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. , 2006, Cancer research.
[24] C. Bräuchle,et al. Cellular dynamics of EGF receptor-targeted synthetic viruses. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] A. Paller,et al. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. , 2007, Cancer research.
[26] Joseph Schlessinger,et al. Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor , 2002, Cell.
[27] R. Langer,et al. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations. , 2008, Cancer research.
[28] S. Schmid,et al. Regulation of signal transduction by endocytosis. , 2000, Current opinion in cell biology.
[29] Peter Klein,et al. On the nature of low- and high-affinity EGF receptors on living cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Mann,et al. Phosphotyrosine interactome of the ErbB-receptor kinase family , 2005, Molecular systems biology.
[31] Boris N. Kholodenko,et al. Untangling the signalling wires , 2007, Nature Cell Biology.
[32] F. Révillion,et al. ERBB2 oncogene in human breast cancer and its clinical significance. , 1998, European journal of cancer.
[33] Roland Eils,et al. An ultrasensitive sorting mechanism for EGF Receptor Endocytosis , 2008, BMC Systems Biology.
[34] Rick Chappell,et al. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control. , 2004, International journal of radiation oncology, biology, physics.
[35] P. Bastiaens,et al. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate , 2007, Nature Cell Biology.
[36] Qian Wang,et al. Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation , 2005, EMBO reports.
[37] S. Schmid,et al. Control of EGF Receptor Signaling by Clathrin-Mediated Endocytosis , 1996, Science.
[38] A. Sorkin,et al. EGF receptor ubiquitination is not necessary for its internalization , 2007, Proceedings of the National Academy of Sciences.
[39] H. Wiley,et al. Receptor-mediated endocytosis in Xenopus oocytes. I. Characterization of the vitellogenin receptor system. , 1987, The Journal of biological chemistry.
[40] A. Citri,et al. EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.
[41] Eytan Domany,et al. A module of negative feedback regulators defines growth factor signaling , 2007, Nature Genetics.
[42] B. Geiger,et al. Alternative Intracellular Routing of ErbB Receptors May Determine Signaling Potency* , 1998, The Journal of Biological Chemistry.
[43] P. Bastiaens,et al. Prolonged EGFR Signaling by ERBB2‐Mediated Sequestration at the Plasma Membrane , 2008, Traffic.
[44] Vladislav V Verkhusha,et al. New lasers for flow cytometry: filling the gaps , 2007, Nature Methods.
[45] Pier Paolo Di Fiore,et al. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation , 2003, Nature Cell Biology.
[46] J. Isola,et al. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival , 2006, Neuropathology and applied neurobiology.
[47] H. Wiley,et al. Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system , 1988, The Journal of cell biology.
[48] H Steven Wiley,et al. Trafficking of the ErbB receptors and its influence on signaling. , 2003, Experimental cell research.
[49] S. Tripp,et al. Epidermal Growth Factor Receptor Gene Amplification and Protein Expression in Glioblastoma Multiforme: Prognostic Significance and Relationship to Other Prognostic Factors , 2006, Applied immunohistochemistry & molecular morphology : AIMM.
[50] R. Tsien,et al. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein , 2004, Nature Biotechnology.
[51] L. E. Johannessen,et al. EGF‐Induced Activation of the EGF Receptor Does Not Trigger Mobilization of Caveolae , 2006, Traffic.
[52] A. Lenferink,et al. Differential endocytic routing of homo‐ and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers , 1998, The EMBO journal.